Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes, through its Synthes GmbH affiliate, announced today that it acquired OrthoSpin.
Israel-based OrthoSpin develops a robot-assisted external fixation system for orthopedic treatments. The platform is used in conjunction with DePuy Synthes’ Maxframe multi-axial correction system, an external ring fixation system.
OrthoSpin received FDA clearance for its second generation, robotic, digitally-enabled G2 external fixation system in January of this year.
According to a news release, the acquisition highlights J&J’s efforts to advance innovation in medtech, with the company having kept tabs on OrthoSpin over the years. OrthoSpin raised $3 million for the external fixation system in a July 2018 Series A funding round led by J&J. The company also led OrthoSpin’s Series B in March 2020.
DePuy Synthes introduced its Maxframe system in 2017 and recently launched new frame innovati…